Sulatha Dwarakanath

Sulatha Dwarakanath, Ph.D., serves as the VP of Assay Product Development at Hemex Health, Inc., focusing on rapid and precise diagnostic solutions. With extensive experience in diagnostics, Sulatha founded and led KAYA17, now multiomeDX, emphasizing women's health. Previous roles include senior management positions at Roche and Thermo Fisher Scientific, where responsibilities encompassed technical marketing and assay development in virology and DNA fingerprinting technologies. Sulatha also co-founded Nano Science Diagnostics, innovating in assay technology and securing partnerships for product development. An academic background includes a Ph.D. in Biochemistry and Molecular Biology from New York University and earlier degrees from Bangalore University and National College.